[Current theories on the pathogenesis and treatment of nocturnal paroxysmal hemoglobinuria (NPH)].
Robak
T
T
Zakładu Farmakologii Klinicznej AM w Lodzi Szpital im. M. Kopernika.
D016026:Bone Marrow Transplantation; D018958:CD55 Antigens; D003167:Complement Activation / Q000276:immunology*; D003176:Complement C3 / Q000276:immunology*; D003169:Complement Inactivator Proteins / Q000172:deficiency*; D004910:Erythrocyte Membrane / Q000276:immunology*; D006457:Hemoglobinuria, Paroxysmal / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D008565:Membrane Proteins / Q000172:deficiency* / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use
D018958:CD55 Antigens; D003176:Complement C3; D003169:Complement Inactivator Proteins; D008565:Membrane Proteins; D013739:Testosterone; D011241:Prednisone
Współczesne poglady na patogeneze i leczenie nocnej napadowej hemoglobinurii (NNH).